Thermo Fisher Scientific to sell microbiology business to Astorg for $1.075bn
Monday, April 27, 2026 · first reported by PE Hub and 1 other
Astorg acquires Thermo Fisher's microbiology business for $1.075B; business serves life science and clinical research customers.
- Firm
- Astorg
- Also named
- Thermo Fisher Scientific
- Deal value
- $1.1B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
2 sourcesMore in Deals
From the same day- Intertek rejects sweetened £8.3bn EQT bidPrivate Equity Wire
- Apollo to acquire Forvia’s automotive interiors businessPE Hub +1
- Bill Ackman's Pershing Square IPO expected to raise $5 billion, sources sayReuters +1
- Blackstone Pays $200M for Another Industrial Portfolio in South FloridaCommercial Observer
- Sullivan Street Partners acquires Mi Hub from LDCPE Hub +1
- Stonepeak and Bernhard Capital to acquire electric utility ClecoPE Hub